Presentation

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

Presenter: Pascal Vranckx

October 14, 2015

REGISTER for free or LOG IN to view this content

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

Presentation

TCT 2015

Up Next

Presentation

FDA-Approved or US IDE Studies: EVOLUT R Technical Specifications and Clinical Trial Results (CE Study and Available US Results)

Presenter: Jeffrey J. Popma

October 14, 2015

More slides +

Presentation

Biomechanical Implications of Scaffold Design on Vascular Biology and Healing

Presenter: Elazer R. Edelman

October 14, 2015

Presentation

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

Presenter: Gregg W. Stone

October 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.